St. Johns Investment Management Company, LLC
Source: SEC Form 13F · as of Mar 2026St. Johns Investment Management Company, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $9.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$9.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 8,463 | $2.1M |
| AMGNAMGEN INC | 5,261 | $1.9M |
| MRKMerck & Co., Inc. | 15,158 | $1.8M |
| ABTABBOTT LABORATORIES | 9,758 | $1.0M |
| ABBVAbbVie Inc. | 4,286 | $932K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,201 | $866K |
| PFEPFIZER INC | 28,802 | $809K |
| REGNREGENERON PHARMACEUTICALS, INC. | 86 | $66K |
| LLYELI LILLY & Co | 51 | $47K |
| PMPhilip Morris International Inc | 200 | $33K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 50 | $17K |
| AZNASTRAZENECA PLC | 29 | $6K |
| NVONovo Nordisk A/S | 38 | $1K |
| GUTSFractyl Health Inc. | 1,980 | $906 |
| OGENORAGENICS INC | 200 | $112 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.